News & Articles

Differentiate human pluripotent stem cells to muscle myotubes

These CAR-T cell therapies are designed to be used in the treatment of hematological malignancies

These kits are designed for rapid and efficient isolation of circulating cell-free DNA

A new cfPure Max kit from AMSBIO is now available for use on samples of 5mLs volume or greater

AMSBIO is advancing stem cell discovery with the GenePORTER 2 reagent for transfection

AMSBIO has introduced human recombinant iMatrix Laminin 211 fragments as a high-quality matrix for basic research, drug development and toxicity studies

AMSBIO has found a reagent to best transfect its human embryonic stem cells

New HCP detection kits are designed to detect the presence of host cell protein impurities at any phase of your therapeutic development

AMSBIO have introduced a new range of proprietary reagents designed for researchers investigating targeted cancer therapy.

AMSBIO introduces new range of solutions to assess the function of PROTACs as a promising therapeutic method

The new range adds to AMSBIO’s growing product offering which includes engineered cell lines that aim to support custom development in applications including animal studies

Leading European research groups use Lipidure coated microplates to help culture physiologically functional, light-responsive retinal organoids

Customized solutions Offered for various surface science applications, particularly nanotechnology, for industrial and academic researchers

Dr. Masato Nakagawa to discuss induced pluripotent stem cells for regenerative research

AMSBIO announces the addition of a novel recombinant cell line, to advance immunotherapy research